// App-Quantinova.ai

2638 : The Cumulative Burden of Damage for Patients with Eosinophilic Granulomatosis with Polyangiitis

Researchers

Presenter

  • David Cuthbertson

Principal Investigators

  • Gunnar Tomasson

  • Simon Carette

  • Nader A. Khalidi

  • Curry L. Koening

  • Carol Langford

  • Carol A. McAlear

  • Larry W. Moreland

  • Paul Monach

  • Philip Seo

  • Ulrich Specks

  • Antoine Sreih

  • Kalen Young

  • Steven Ytterberg

  • Peter A. Merkel

  • Christian Pagnoux

Medical Centers

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • University of South Florida, Tampa, FL

  • Faculty of Medicine, University of Iceland and Landpitali University Hospital, Reykjavik, Iceland

  • McMaster University, Hamilton, ON, Canada

  • University of Utah, Salt Lake City, UT

  • Cleveland Clinic, Cleveland, OH

  • University of Pennsylvania - VCRC Project Manager, Philadelphia, PA

  • University of Pittsburgh, Pittsburgh, PA

  • Brigham and Women's Hospital, Brookline, MA

  • Johns Hopkins Medicine, Baltimore, MD

  • Mayo Clinic College of Medicine, Rochester, MN

  • University of Pennsylvania, Philadelphia, PA

  • The Vasculitis Foundation, Kansas City, MO

  • University of Pennsylvania, Philadelphia, PA

  • University of Pennsylvania Division of Cardiology, Philadelphia, PA

Locations

  • Canada

  • United States

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

Biomarkers

  • Cytochrome C

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Glucocorticoid

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A